Osanni Bio — Valuation, Funding & Investors

Recent changes

Jun 26, 2026Jun 26, 2026Raised $190M Series B Crunchbase News
Jun 26, 2026Jun 26, 2026Osanni Bio Lands $190M Series B to Advance Its Therapeutics Platform Pulse story

Funding History

1 event · sources dated per row

Date	Event	Amount	Valuation	Investors	Source
Jun 26, 2026	Series B	$190M	—		Pulse story

Latest Pulse

Jun 26, 2026Osanni Bio Lands $190M Series B to Advance Its Therapeutics PlatformOsanni Bio raised a $190 million Series B led by Patient Square Capital to push its therapeutics platform deeper into clinical development. The large biotech round underscores that 2026's reopening capital markets are not an AI-only story -- life sciences is once again drawing big checks and, increasingly, big exits.→

Coverage Timeline

newest first

Jun 26, 2026FUNDINGOsanni Bio Lands $190M Series B to Advance Its Therapeutics Platform$190M→

All Coverage

FUNDING· Jun 26, 2026

Osanni Bio Lands $190M Series B to Advance Its Therapeutics Platform

FUNDING$190M

Osanni Bio Lands $190M Series B to Advance Its Therapeutics Platform

Osanni Bio raised a $190 million Series B led by Patient Square Capital to push its therapeutics platform deeper into clinical development. The large biotech round underscores that 2026's reopening capital markets are not an AI-only story -- life sciences is once again drawing big checks and, increasingly, big exits.

Jun 26, 2026

Related Companies

Same sector

Attovia Therapeutics Apnimed Braveheart Bio Latigo Biotherapeutics Scribe Therapeutics

Sources & methodologyshow

Where these figures come from

Crunchbase Newsresearch database1 fact

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data · Suggest a correction